Quality by design optimisation of isothermal dry particle coating for enhanced buccal permeation of vancomycin

1. Caffarel-Salvador, E. et al. Oral delivery of biologics using drug-device combinations. Curr. Opin. Pharmacol. 36, 8–13 (2017).

   Google Scholar 

2. Durán-Lobato, M., Niu, Z. & Alonso, M. J. Oral delivery of biologics for precision medicine. Adv. Mater. 32(13), 1901935 (2020).

   Google Scholar 

3. Buntz, B. Best-selling pharmaceuticals of 2023 reveal a shift in pharma landscape (Drug Discovery & Development, 2024). Available from: https://www.drugdiscoverytrends.com/best-selling-pharmaceuticals-2023/

4. Manalac, T. 10 Best-Selling Drugs of 2024 Rake in Billions Amid Exclusivity Threats (2025). Available from: https://www.biospace.com/business/10-best-selling-drugs-of-2024-rake-in-billions-amid-exclusivity-threats

5. Anselmo, A. C., Gokarn, Y. & Mitragotri, S. Non-invasive delivery strategies for biologics. Nat. Rev. Drug Discov. 18(1), 19–40 (2019).

   Google Scholar 

6. Clarkson, B. R., Schön, A. & Freire, E. Conformational stability and self-association equilibrium in biologics. Drug Discov. Today. 21(2), 342–347 (2016).

   Google Scholar 

7. Morrow, T. & Felcone, L. H. Defining the difference: What makes biologics unique. Biotechnol. Healthc. 1 (4), 24–29 (2004).

   Google Scholar 

8. Rajabi, A. et al. Evaluating the role of amino acids and isothermal dry particle coating in modulating buccal permeation of large molecule drug vancomycin. Sci. Rep. 14 (1), 19678 (2024).

   Google Scholar 

9. Juran, J. M. Juran on Quality by Design: The New Steps for Planning Quality into Goods and Services (Simon and Schuster, 1992).

10. Guideline, I. H. T. ICH Q8 (R2) pharmaceutical development. In International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (2009).

11. Yu, L. X. et al. Understanding pharmaceutical quality by design. AAPS J. 16(4), 771–783 (2014).

    Google Scholar 

12. Dahmash, E. Z. et al. Quality by design (QbD) based process optimisation to develop functionalised particles with modified release properties using novel dry particle coating technique. PLoS One. 13(11), e0206651 (2018).

    Google Scholar 

13. Rana, H. et al. Atovaquone smart lipid system: Design, statistical optimization, and in-vitro evaluation. Food Hydrocoll. Health. 4, 100144 (2023).

    Google Scholar 

14. Guideline, I. H. T. ICH guideline Q9 (R1) on quality risk management. In International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (2023).

15. Fukuda, I. M. et al. Design of experiments (DoE) applied to pharmaceutical and analytical quality by design (QbD). Brazilian J. Pharm. Sci. 54, e01006 (2018).

16. Duarte, J. G. et al. Rethinking pharmaceutical industry with quality by design: Application in research, development, manufacturing, and quality assurance. AAPS J. 27(4), 96 (2025).

    Google Scholar 

17. Rana, H. et al. Intelligent industry-oriented oro-solid formulation of famotidine: advanced statistical optimization and ex-vivo characterization. Results Chem. 10, 101753 (2024).

    Google Scholar 

18. Rellahan, B. L., Vinci, V. & McLeod, L. D. QbD for Biologics Learning from the Product Development and Realization (A-MAb) Case Study and the FDA OBP Pilot Program (2012).

19. Sreedhara, A. et al. Application of QbD Principles to Late-Stage Formulation Development for Biological Liquid Products 7.1 Introduction (2015).

20. Iyire, A., Alaayedi, M. & Mohammed, A. R. Pre-formulation and systematic evaluation of amino acid assisted permeability of insulin across in vitro buccal cell layers. Sci. Rep. 6, 32498 (2016).

    Google Scholar 

21. Sullivan, B. P. et al. Pulmonary delivery of vancomycin dry powder aerosol to intubated rabbits. Mol. Pharm. 12(8), 2665–2674 (2015).

    Google Scholar 

22. Hu, C., Beyda, N. D. & Garey, K. W. A Vancomycin HPLC Assay for Use in Gut Microbiome Research. e01688-21 (Microbiology Spectrum, 2022).

23. Dahmash, E. Z. & Mohammed, A. R. Characterisation and surface-profiling techniques for composite particles produced by dry powder coating in pharmaceutical drug delivery. Drug Discov. Today. 21(4), 550–561 (2016).

    Google Scholar 

24. Samiei, N. et al. Ion-pair strategy for enabling amifostine oral absorption: rat in situ and in vivo experiments. Eur. J. Pharm. Sci. 49(4), 499–504 (2013).

    Google Scholar 

25. Marianni, B., Polonini, H. & Oliveira, M. A. L. Ensuring homogeneity in powder mixtures for pharmaceuticals and dietary supplements: evaluation of a 3-Axis mixing equipment. Pharmaceutics, 13(4), 563 (2021).

26. Mendez, A. S. L., de Carli, G. & Garcia, C. V. Evaluation of powder mixing operation during batch production: Application to operational qualification procedure in the pharmaceutical industry. Powder Technol. 198(2), 310–313 (2010).

    Google Scholar 

27. Jakubowska, E. & Ciepluch, N. Blend segregation in tablets manufacturing and its effect on drug content uniformity—A review. Pharmaceutics, 13(11), 1909 (2021).

28. Cristofoli, M. et al. Ion pairs for transdermal and dermal drug delivery: A review. Pharmaceutics, 13(6), 909 (2021).

29. Sikora, K. et al. The role of Counter-Ions in Peptides-An overview. Pharmaceuticals (Basel), 13(12), 442 (2020).

30. Commission, B. P. & Commission, G. B. M. British Pharmacopoeia 2000 Vol. 1 (Bernan Press (PA), 2000).

31. Revision, U.S.P.C.C.O. The United States Pharmacopeia (United States Pharmacopeial Convention, 1985).

32. Jacobsen, J. et al. TR146 cells grown on filters as a model for human buccal epithelium: I. Morphology, growth, barrier properties, and permeability. Int. J. Pharm. 125(2), 165–184 (1995).

    Google Scholar 

33. Iyire, A., Alaayedi, M. & Mohammed, A. R. Pre-formulation and systematic evaluation of amino acid assisted permeability of insulin across in vitro buccal cell layers. Sci. Rep. 6(1), 32498 (2016 ).

    Google Scholar 

34. UMETRICS, S. P. User Guide and Tutorial (Société Umetrics, 2005).

35. Hespanhol, L. et al. Understanding and interpreting confidence and credible intervals around effect estimates. Braz J. Phys. Ther. 23(4), 290–301 (2019).

    Google Scholar 

36. Marcus, Y. & Hefter, G. Ion pairing. Chem. Rev. 106(11): 4585–4621. (2006).

    Google Scholar 

37. Brown, T. L. et al. Chemistry: The Central Science (Pearson Higher Education AU, 2013).

38. Ma, L. et al. CFD-DEM simulations of particle separation characteristic in centrifugal compounding force field. Powder Technol. 343, 11–18 (2019).

    Google Scholar 

39. Hartley, P. A., Parfitt, G. D. & Pollack, L. B. The role of the Van der Waals force in the agglomeration of powders containing submicron particles. Powder Technol. 42(1), 35–46 (1985).

    Google Scholar 

40. Tanaka, R. et al. In-line and real-time monitoring of resonant acoustic mixing by Near-infrared spectroscopy combined with chemometric technology for process analytical technology applications in pharmaceutical powder blending systems. Anal. Sci. 33(1), 41–46 (2017).

    Google Scholar 

41. Mittal, B. Chap. 4 – Pharmaceutical unit operations. In How To Develop Robust Solid Oral Dosage Forms from Conception To Post-Approval edi. by B. Mittal, 69–95 (Academic, 2017).

42. Mohammed, A. et al. Fluidised powder blending to control particle-particle interaction–the future of DPI formulation. in Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2019. Mary Ann Liebert, Inc 140 Huguenot Street, 3rd Fl, New Rochelle, NY 10801 USA.

43. Sager, T. M. & Castranova, V. Surface area of particle administered versus mass in determining the pulmonary toxicity of ultrafine and fine carbon black: Comparison to ultrafine titanium dioxide. Part. Fibre Toxicol. 6(1), 15 (2009).

    Google Scholar 

44. Visser, J. Van der Waals and other cohesive forces affecting powder fluidization. Powder Technol. 58(1), 1–10 (1989).

    Google Scholar 

45. Harley, S., Thompson, D. W. & Vincent, B. The adsorption of small particles onto larger particles of opposite charge direct electron microscope studies. Colloids Surf. 62(1), 163–176 (1992).

    Google Scholar 

46. Friebel, J. M. et al. Three-dimensional characterization of dry particle coating structures originating from the mechano-fusion process. Microsc. Microanal. 30(2), 179–191 (2024).

    Google Scholar 

47. Ouabbas, Y. et al. Particle–particle coating in a cyclomix impact mixer. Powder Technol. 189(2), 245–252 (2009).

    Google Scholar 

48. Wei, L. & Chen, Q. Calculation of drag force on an object settling in gas-solid fluidized beds. Part. Sci. Technol. 19(3), 229–238 (2001).

    Google Scholar 

49. Dourmashkin, P. Classical Mechanics, Drag forces in fluids. Libre texts project. MIThttps://phys.libretexts.org/Bookshelves/Classical_Mechanics/Classical_Mechanics_(Dourmashkin)/08%3A_Applications_of_Newtons_Second_Law/8.06%3A_Drag_Forces_in_Fluids

50. Brzinski, T. A. & Durian, D. J. Drag Force in a Gas Fluidized Granular Bed (Bulletin of the American Physical Society, 2008).

51. Grasmeijer, F. et al. Mixing time effects on the dispersion performance of adhesive mixtures for inhalation. PLoS One. 8(7), e69263 (2013).

    Google Scholar 

52. Sato, A. et al. Experiment and simulation of the dry particle coating. Chemical engineering science 86, 164–172 (2011).

53. Selvam, P. & Smyth, H. D. C. Effect of press-on forces on drug adhesion in dry powder inhaler formulations. J. Adhes. Sci. Technol. 25(14), 1659–1670 (2011).

    Google Scholar 

54. Xie, L. et al. Dispersion of Nano-Particle Clusters Using Mixed Flow and High Shear Impellers in Stirred Tanks Vol. 85, 676–684 (Chemical Engineering Research & Design, 2007).

55. Jing, S. W. et al. Industrial untapped rotational kinetic energy assessment for sustainable energy recycling. Energy Eng. 122(3), 905–927 (2025).

    Google Scholar 

56. Umetrics, S. P. MODDE, User Guide and Tutorial (2021).https://www.sartorius.com/download/544636/modde-12-user-guide-en-b-00090-sartorius-data.pdf

57. ElShaer, A., Hanson, P. & Mohammed, A. R. A novel concentration dependent amino acid ion pair strategy to mediate drug permeation using indomethacin as a model insoluble drug. Eur. J. Pharm. Sci. 62, 124–131 (2014).

    Google Scholar 

58. Neubert, R. Ion pair transport across membranes. Pharm. Res. 6(9), 743–747 (1989).

    Google Scholar 

59. Cano-Cebrián, M. J. et al. Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: A target for drug delivery. Curr. Drug Deliv. 2(1), 9–22 (2005).

    Google Scholar 

60. Masich, A. M. et al. Vancomycin pharmacokinetics in obese patients with sepsis or septic shock. Pharmacother. J. Hum. Pharmacol. Drug Ther.. 40(3), 211–220 (2020).

    Google Scholar 

61. Nielsen, H. M. & Rassing, M. R. TR146 cells grown on filters as a model of human buccal epithelium: III. Permeability enhancement by different pH values, different osmolality values, and bile salts. Int. J. Pharm. 185(2), 215–225 (1999).

    Google Scholar 

62. Montgomery, D. C. Design and Analysis of Experiments (Wiley, Hoboken, 2017).

Download references